Vimal H. Prajapati

Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis

Andrew Blauvelt, Henrique D. Teixeira, Eric L. Simpson et al. · JAMA Dermatology · 2021 · 451 citations · Full text

Distinct Cutaneous Manifestations and Cold-Induced Leukocyte Activation Associated With<i>PLCG2</i>Mutations

Oyinade Aderibigbe, Debra Long Priel, Chyi‐Chia Richard Lee et al. · JAMA Dermatology · 2015 · 66 citations · Full text

Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)

Brett King, Maryanne M. Senna, Natasha Atanaskova Mesinkovska et al. · Journal of the American Academy of Dermatology · 2024 · 63 citations · Full text

Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis

Amy S. Paller, Barry Ladizinski, Pedro Mendes‐Bastos et al. · JAMA Dermatology · 2023 · 56 citations · Full text

Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: A post hoc integrated analysis of 3 phase 3 randomized, double-blind, placebo-controlled trials

Pedro Mendes‐Bastos, Barry Ladizinski, Emma Guttman‐Yassky et al. · Journal of the American Academy of Dermatology · 2022 · 55 citations · Full text